[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-451835-105":59,"doc-detail-451835-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","cpht-knowledge-reference-ptce-knowledge-areas","CPhT Knowledge Reference - PTCE Knowledge Areas","","Guide to the PTCE content knowledge areas for pharmacy technicians (CPhTs), organizing statements into blue required, white required, and gray recommended categories. Covers medication knowledge (naming, therapeutic equivalence, interactions, dose and handling, side effects, indications, stability, NTI drugs, incompatibilities, storage), federal compliance for hazardous and controlled substances, and pharmacy practice standards across federal and state requirements. Includes patient safety and quality assurance topics such as LASA medications, error prevention, pharmacist interventions, event reporting, prescription error types, and hygiene.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":20,"@type":76,"position":81},"https://docshare.wps.com/document/exam/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cpht-knowledge-reference-ptce-knowledge-areas/451835/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cpht-knowledge-reference-ptce-knowledge-areas/451835.png","ImageObject",300,407,{"name":92,"@type":93},"8796093062539","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-08","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What areas of patient safety and quality assurance does the document address?","Question",{"text":112,"@type":113},"It addresses high-alert/LASA medications, error prevention strategies, issues requiring pharmacist intervention, event reporting procedures, types of prescription errors, and hygiene and cleaning standards such as handwashing and PPE.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},451835,1790801401,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":19,"category_name":20,"doc_title":65,"doc_description":67,"doc_content":125,"file_id":126,"file_url":127,"file_type":128,"file_size":129,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":130,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":131,"faqs":132,"seo_title":133,"seo_description":67,"update_tm":134,"read_time":135},8796093062539,"How to Use This Document  \n\n| PTCE Knowledge Areas\u003Cbr>Statements appearing on the PTCE Content Outline are highlighted in blue ; those requiring calculationsbased knowledge are denoted with an asterisk (*) . These blue statements are required of competent CPhTs and demonstrated primarily by passing the PTCE. | Required\u003Cbr>White knowledge statements are also required of competent CPhTs and demonstrated through education/training or a combination of work experience and other preparation activities. | Recommended\u003Cbr>Gray knowledge statements are recommended for competent CPhTs, but not required. |\n| --- | --- | --- |\n|  | For white and gray statements, only a basic/definitional understanding is expected. |  |\n\nMedications  \n\n| PTCE Knowledge Areas\u003Cbr>1.1 Generic names, brand names, and classifications of medications\u003Cbr>1.2 Therapeutic equivalence\u003Cbr>1.3 Common and life-threatening drug interactions and contraindications (e.g. , drug-disease, drug-drug, drug-dietary supplement, drug-laboratory, drugnutrient)\u003Cbr>1.4* Strengths/dose, dosage forms, routes of administration, special handling and administration instructions, and duration of drug therapy\u003Cbr>1.5 Common and severe medication side effects, adverse effects, and allergies\u003Cbr>1.6 Indications of medications and dietary supplements\u003Cbr>1.7* Drug stability (e.g. , oral suspensions, insulin, reconstitutables, injectables, vaccinations)\u003Cbr>1.8 Narrow therapeutic index (NTI) medications\u003Cbr>1.9 Physical and chemical incompatibilities related to non-sterile compounding and reconstitution\u003Cbr>1.10 Proper storage of medications (e.g. , temperature ranges, light sensitivity, restricted access) | Required\u003Cbr>Intentionally blank | Recommended\u003Cbr>Intentionally blank |\n| --- | --- | --- |\n\nFederal Requirements  \n\n| PTCE Knowledge Areas\u003Cbr>2.1 Federal requirements for handling and disposal of non-hazardous, hazardous, and pharmaceutical substances and waste\u003Cbr>2.2* Federal requirements for controlled substance prescriptions (i.e. , new, refill, transfer) and DEA controlled substance schedules\u003Cbr>2.3 Federal requirements (e.g. , DEA, FDA) for controlled substances (i.e. , receiving, storing, ordering, labeling, dispensing, reverse distribution, take-back programs, and loss or theft of)\u003Cbr>2.4* Federal requirements for restricted drug programs and related medication processing (e.g. , pseudoephedrine, Risk Evaluation and Mitigation Strategies [REMS])\u003Cbr>2.5 FDA recall requirements (e.g. , medications, devices, supplies, supplements, classifications) | Required\u003Cbr>• Federal requirements (e.g. , DEA, FDA) for receiving, ordering, refilling, labeling, dispensing, returning, take-back programs, and loss or theft of non-controlled substances\u003Cbr>• OSHA requirements for prevention and treatment of hazardous substances exposure (e.g. , eyewash, spill kit)\u003Cbr>• DEA requirements for record keeping, documentation, and record retention (i.e. , minimum length of time controlled substances and records are maintained on file)\u003Cbr>• OSHA Hazard Communication Standard (i.e. ,“Employee Right to Know”)\u003Cbr>• Federal requirements for availability of medications (i.e. , Rx, OTC, behind the counter)\u003Cbr>• Federal requirements for non-controlled substance prescription transfer\u003Cbr>• FDA requirements for consumer medication information and Medication Guides\u003Cbr>• Methods to electronically verify a prescriber’s DEA number\u003Cbr>• OBRA-90 requirement for consultation\u003Cbr>• Process to determine the state, federal, and local laws and regulations that apply to one’s practice site\u003Cbr>• HIPAA requirements for confidentiality | Recommended\u003Cbr>• FDA requirements for receiving, storing, ordering, labeling, dispensing, returning, and loss or theft of investigational drugs\u003Cbr>• OSHA requirements for addressing bloodborne pathogen exposure (e.g. , accidental needle stick, post-exposure prophylaxis [PEP])\u003Cbr>• ADA requirements to address patient physical limitations (e.g. , easy-off caps, increased font size, script-talk machines, braille)\u003Cb","cbCaidENWWBsdbKx","https://ap.wps.com/l/cbCaidENWWBsdbKx","pdf",226941,"English","# How to Use This Document\n# Medications\n# Federal Requirements\n# State Requirements and Practice Standards\n# Patient Safety and Quality Assurance","[{\"question\":\"What areas of patient safety and quality assurance does the document address?\",\"answer\":\"It addresses high-alert/LASA medications, error prevention strategies, issues requiring pharmacist intervention, event reporting procedures, types of prescription errors, and hygiene and cleaning standards such as handwashing and PPE.\"}]","CPhT Knowledge Reference - PTCE Knowledge Areas | PDF",1790736009,18]